肱骨节段间切除重建中血管化腓骨自体移植能否实现长期持久重建
本研究回顾性分析1987年至2021年间18例因原发骨肿瘤行肱骨骨干节段间切除并采用血管化腓骨移植(VFG)重建的患者,中位随访176个月,中位MSTS评分30分、ASES评分98.3分、Constant评分93.5%,5年无翻修生存率71%、10年和15年均为57%,VFG取出无生存率5年、10年、15年均为94%。作者认为VFG似乎是肱骨节段间切除后有效的重建选择,但并发症在术后早期可能较频繁。
要点
- 18例肱骨骨干节段间切除后VFG重建患者中,7例接受翻修手术,1例取出VFG。
- 中位随访176个月时,中位MSTS评分30分(范围28-30),中位ASES评分98.3(范围93-100),中位Constant评分93.5%(范围79%-100%)。
- 无翻修生存率5年71%(95%CI 53%-96%),10年和15年均为57%(95%CI 37%-88%);VFG取出无生存率5年、10年、15年均为94%(95%CI 83%-100%)。
核心结论
- VFG似乎是肱骨节段间切除治疗原发骨肿瘤后有效的重建选择。
- 这些是复杂手术,应由经验丰富的外科团队施行,并认识到术后最初几年并发症可能较频繁。
- 术后5年内观察到的机械并发症频率可能通过使用长跨度钢板固定来减少,若成功,该重建可提供长期持久重建和优良功能结果。
研究设计与样本
- 回顾性研究,1987年至2021年间在本机构连续治疗127例因肱骨原发恶性或侵袭性良性骨肿瘤行整块切除的患者,其中14%(127例中18例)行肱骨骨干节段间切除并VFG重建(伴或不伴大块异体骨),纳入分析。
- 18例中13例单独使用VFG,5例使用VFG联合大块异体骨。
- 所有18例均至少随访2年,中位随访176个月(范围26-275个月);3例过去5年未就诊且未知是否死亡,随访分别为172、163、236个月,仍纳入分析。
- 手术时中位年龄25岁(范围2-63岁),中位肱骨切除长度15 cm(范围8-21 cm),中位腓骨长度16 cm(范围12-23 cm)。
- 功能评分由未参与患者照护的人员通过病历回顾评估,采用MSTS评分(范围0-30)、ASES评分(范围0-100)和Constant评分(范围0%-100%);生存率采用Kaplan-Meier法估计。
主要发现
- 7例患者接受翻修手术:1例因螺钉撞击致桡神经暂时性麻痹,3例患者中4处骨不连(其中1例肱骨头缺血性坏死),1例因螺钉相关疼痛治疗,2例VFG骨折;1例患者取出VFG。
- 供区并发症4例:1例踝外翻畸形,3例爪形趾(2例为第一趾,1例为其他足趾)。
- 末次临床对照中位随访176个月(范围26-275个月)时,中位MSTS评分30分(范围28-30),中位ASES评分98.3(范围93-100),中位Constant评分93.5%(范围79%-100%)。
- 无翻修生存率5年71%(95%CI 53%-96%),10年和15年均为57%(95%CI 37%-88%);VFG取出无生存率5年、10年、15年均为94%(95%CI 83%-100%)。
关键数值与推荐
- 本机构VFG重建指征一般为:因原发恶性或侵袭性良性骨肿瘤行肱骨节段间切除,患者预期寿命长且功能需求高,近端和远端骨骺骨量充足可保留。
- 本机构的策略是:对行近关节保关节切除、近端截骨靠近肱骨解剖颈的患者,使用VFG联合大块异体骨,以获得更稳定固定和更好的肩袖及三角肌肌腱再附着。
- 功能评估采用MSTS评分(范围0-30)、ASES评分(范围0-100)和Constant评分(范围0%-100%)。
- 证据等级为Level IV,治疗性研究。
临床怎么用
- 作者认为VFG似乎是肱骨节段间切除治疗原发骨肿瘤后有效的重建选择。
- 作者指出这些是复杂手术,应由经验丰富的外科团队施行,并认识到术后最初几年并发症可能较频繁。
- 作者认为术后5年内观察到的机械并发症频率可能通过使用长跨度钢板固定来减少。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A vascularized fibula graft (VFG) is the vascular autograft most frequently used to restore large segmental long bone defects, particularly in the upper limb. Because the use of a vascularized fibula involves an operation in an uninvolved extremity with potential morbidity, it is important to document that this type of reconstruction is successful in restoring function to the humerus. However, the long-term results of VFG after intercalary resection of the humeral diaphysis for bone tumors are still unknown. QUESTIONS/PURPOSES: (1) What was the complication rate of reconstruction? (2) What was the functional result after surgical treatment, as assessed by the Musculoskeletal Tumor Society (MSTS) score, the American Shoulder and Elbow Society (ASES) score, and Constant score? (3) What was the survivorship of these grafts free from revision and graft removal at 5, 10, and 15 years? METHODS: Between 1987 and 2021, 127 patients were treated at our institution with en bloc resection for a primary malignant or an aggressive benign bone tumor of the humerus; we excluded patients treated with extra-articular resection or amputation. Of those, 14% (18 of 127) were treated with intercalary resection of the humeral diaphysis for primary bone tumors and reconstruction with VFG, with or without a bulk allograft, and were analyzed in this retrospective study. Generally, our indications for reconstruction with VFG are intercalary resection of the humerus for primary malignant or aggressive benign bone tumors in patients with long life expectancy and high functional demands, in whom adequate bone stock of the proximal and distal epiphysis can be preserved. In 13 patients, VFG was used alone, whereas in five patients, a massive allograft was used. Our policy was to use VFG combined with a massive allograft in patients undergoing juxta-articular joint-sparing resections in which proximal osteotomy was performed close to the anatomic neck of the humerus to obtain more stable fixation and better tendinous reattachment of the rotator cuff and deltoid. All 18 patients who were treated with a VFG were available for follow-up at a minimum of 2 years (median follow-up 176 months, range 26 to 275 months), and although three have not been seen in the past 5 years and are not known to have died, they had 172, 163, and 236 months of follow-up, and were included. The median age at surgery was 25 years (range 2 to 63 years), the median humeral resection length was 15 cm (range 8 to 21 cm), and the median fibular length was 16 cm (range 12 to 23 cm). Complications and functional scores were ascertained by chart review that was performed by an individual not involved in patient care. Functional results were assessed with the MSTS score (range 0 to 30), the ASES score (range 0 to 100), and the Constant score (range 0% to 100%). Survivorship was estimated using a Kaplan-Meier survivorship estimator, which was suitable because there were few deaths in this series. RESULTS: Seven patients underwent a revision procedure (one radial nerve transient palsy because of screw impingement, four nonunions in three patients with one humeral head avascular necrosis, treatment for screw-related pain in one patient, and two VFG fractures), and one patient underwent VFG removal. Donor site complications were observed in four patients (one ankle valgus deformity and three claw toes-the first toe in two patients and the other toes in the third). At the final clinical control, at a median follow-up of 176 months (range 26 to 275 months), the median MSTS score was 30 of 30 (range 28 to 30), the median ASES score was 98.3 (range 93 to 100), and the median Constant score was 93.5% (range 79% to 100%). Revision-free survival was 71% (95% CI 53% to 96%) at 5 years and 57% (95% CI 37% to 88%) at 10 and 15 years; VFG removal-free survival was 94% (95% CI 83% to 100%) at 5, 10, and 15 years. CONCLUSION: VFG appears to be an effective reconstructive option after humeral intercalary resection for primary bone tumors. These are complex procedures and should be performed by an experienced team of surgeons who recognize that complications may occur frequently in the first years after the procedure. The frequency of mechanical complications observed in the first 5 years postoperatively may be lessened by using long spanning-plate fixation, and if successful, this reconstruction provides a long-term, durable reconstruction with excellent functional results. LEVEL OF EVIDENCE: Level IV, therapeutic study.
引用
- Campanacci DA, Scanferla R, Innocenti M, et al. Are Vascularized Fibula Autografts a Long-lasting Reconstruction After Intercalary Resection of the Humerus for Primary Bone Tumors? Clin Orthop Relat Res. 2023. PMID: 37364172. doi:10.1097/CORR.0000000000002739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。